Evidence map›Paper›PMID 33789666›Full record

ArticleBiomedical engineering online2021

Ensemble deep model for continuous estimation of Unified Parkinson's Disease Rating Scale III.

Murtadha D Hssayeni, Joohi Jimenez-Shahed, Michelle A Burack, Behnaz Ghoraani

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. End-to-end design of wearable sensors.Nature reviews. Materials · 2022
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Murtadha D HssayeniDepartment of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, 33431, USA.
Joohi Jimenez-ShahedIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Michelle A BurackDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
Behnaz GhoraaniDepartment of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, 33431, USA. bghoraani@fau.edu.ORCID http://orcid.org/0000-0003-0075-7663
Florida Atlantic University · USIcahn School of Medicine at Mount Sinai · USUniversity of Rochester Medical Center · US

Funding

Kinesia-D: Ambulatory PD Dyskinesia Monitor for Drug Therapy TitrationR44AG044293 · NIA · GREAT LAKES NEUROTECHNOLOGIES · PI PULLIAM, CHRISTOPHER LEE · 2013 to 2014
$1.7M
Kinesia-D: Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy TitR43NS071882 · NINDS · GREAT LAKES NEUROTECHNOLOGIES · PI MERA, THOMAS OLIVER · 2011 to 2011
$237k
NIA NIH HHS R44 AG044293NINDS NIH HHS R43 NS071882
6 · The paper itself

Abstract

backgroundUnified Parkinson Disease Rating Scale-part III (UPDRS III) is part of the standard clinical examination performed to track the severity of Parkinson's disease (PD) motor complications. Wearable technologies could be used to reduce the need for on-site clinical examinations of people with Parkinson's disease (PwP) and provide a reliable and continuous estimation of the severity of PD at home. The reported estimation can be used to successfully adjust the dose and interval of PD medications.

methodsWe developed a novel algorithm for unobtrusive and continuous UPDRS-III estimation at home using two wearable inertial sensors mounted on the wrist and ankle. We used the ensemble of three deep-learning models to detect UPDRS-III-related patterns from a combination of hand-crafted features, raw temporal signals, and their time-frequency representation. Specifically, we used a dual-channel, Long Short-Term Memory (LSTM) for hand-crafted features, 1D Convolutional Neural Network (CNN)-LSTM for raw signals, and 2D CNN-LSTM for time-frequency data. We utilized transfer learning from activity recognition data and proposed a two-stage training for the CNN-LSTM networks to cope with the limited amount of data.

resultsThe algorithm was evaluated on gyroscope data from 24 PwP as they performed different daily living activities. The estimated UPDRS-III scores had a correlation of [Formula: see text] and a mean absolute error of 5.95 with the clinical examination scores without requiring the patients to perform any specific tasks.

conclusionOur analysis demonstrates the potential of our algorithm for estimating PD severity scores unobtrusively at home. Such an algorithm could provide the required motor-complication measurements without unnecessary clinical visits and help the treating physician provide effective management of the disease.

Indexed as

Deep LearningParkinson DiseaseWearable Electronic DevicesAgedAlgorithmsFemaleHumansMaleMiddle AgedNeural Networks, ComputerSeverity of Illness IndexSignal Processing, Computer-AssistedDeep modelsEnsembleHome monitoringInertial sensorsParkinson’s diseaseUPDRSWearable sensors

Identifiers

PMID33789666
PMCPMC8010504
OpenAlexW3151382523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.